SCHEMBL8615723

SCHEMBL8615723

CN1CCC(C(=O)c2ccc3c(c2)N(Cc2ccccc2)CC3)CC1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 10/20 0.59
HTR2A P28223 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177893 0.81 ACHE (0.63) ACHE
SCHEMBL30027318 0.79 ACHE (0.57) ACHE
SCHEMBL23754421 0.79 ACHE (0.57) ACHE
SCHEMBL8617331 0.75 ACHE (0.46) ACHEHTR2A
SCHEMBL6840328 0.74 ACHE (0.54) ACHE
SCHEMBL8618766 0.74 FLT3 (0.52) ACHEHTR2A
SCHEMBL697874 0.74 ALOX5 (0.56) ACHE
SCHEMBL16587413 0.73 SLC22A12 (0.71) ACHE
SCHEMBL2552838 0.72 HTR2A (0.62) HTR2A
SCHEMBL118883 0.72 HDAC1 (0.53) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050346-A2 ACETAMIDE AND UREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed